Clik here to view.
「武田グローバル本社」のグランドオープンについて
大阪 （ビジネスワイヤ） — 武田薬品工業株式会社（東証：4502）は、本日、「武田グローバル本社」（所在地：東京都中央区日本橋本町）をグランドオープンしましたのでお知らせいたします。「武田グローバル本社」は、世界中で事業を展開する武田薬品のグローバル本社として本年3月に竣工しました。...
View ArticleClik here to view.
TRIGR Therapeutics and ABL Bio Announce Global Oncology Collaboration on...
IRVINE, Calif. TRIGR Therapeutics, a US-based Biopharmaceutical company, and ABL Bio Corporation, a South Korean biotechnology company, jointly announced today that it had entered into a binding...
View ArticleClik here to view.
Gore Announces First Commercial In-Human Use of GORE® TAG® Conformable...
FLAGSTAFF, Ariz. W. L. Gore & Associates, Inc. (Gore) today announced the first patient implant of the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System after being included...
View ArticleClik here to view.
前立腺がんに対する新たな放射線治療 SpaceOAR®ハイドロゲルがついに日本で販売開始
東京 （ビジネスワイヤ） — オーグメニックス株式会社は、前立腺と直腸の間に留置する合成吸収性スペーサーであるSpaceOARハイドロゲルが保険収載され、前立腺がんの放射線治療を受ける全ての患者に使用できるようになったと発表しました。SpaceOARハイドロゲルは、前立腺がんに対する放射線治療を行う際に懸念される副作用の低減において臨床的な有用性が示されています。1,2...
View ArticleClik here to view.
New Radiotherapy Prostate Cancer Treatment, SpaceOAR® Hydrogel, Now Available...
TOKYO Augmenix K.K. announces that SpaceOAR hydrogel, a soft, implanted absorbable gel spacer is now available to all prostate cancer radiotherapy patients in Japan through the Ministry of Health,...
View ArticleClik here to view.
武田全球总部盛大揭幕
日本大阪 (美国商业资讯)–武田药品工业株式会社（“武田”）(TOKYO:4502)今天举行了武田全球总部盛大揭幕典礼。大楼于2018年3月竣工，将作为武田全球运营的总部。 在盛大的揭幕典礼上，创意总监Kashiwa Sato (SAMURAI, Inc.)、武田总裁兼首席执行官Christophe Weber及负责管理本项目的武田企业战略及首席执行官办公室主任Yasuhiro...
View ArticleClik here to view.
Menarini and Orion Sign Regional Partnerships in Asia-Pacific
SINGAPORE A. Menarini Asia-Pacific Holdings Pte Ltd (“Menarini Asia-Pacific”), a member of the Italian largest biopharmaceutical company Menarini Group, and Orion Corporation have signed a...
View ArticleClik here to view.
美纳里尼和奥立安签署亚太区区域合作伙伴协议
新加坡 美纳里尼亚太公司 (A. Menarini Asia-Pacific Holdings Pte Ltd, 以下简称(”美纳里尼亚太公司”)为意大利最大的生物制药公司——美纳里尼集团成员，和奥立安集团 (Orion Corporation)签署了一份数年的许可协议，据此，美纳里尼亚太公司有权在亚太区10个国家和地区内经销以及在商业上推行奥立安集团的多款茜乐® (Easyhaler®)...
View ArticleClik here to view.
First Volunteers Dosed in Phase I Clinical Trial of PBT434, Prana’s Lead...
MELBOURNE, Australia & SAN FRANCISCO Prana Biotechnology Ltd (ASX PBT: NASDAQ PRAN) is pleased to announce the first cohort of volunteers in its Phase I clinical trial have been administered...
View ArticleClik here to view.
Morinaga Milk Obtains Self-Affirmed GRAS Status for Its Proprietary...
TOKYO Morinaga Milk Industry Co., Ltd., (TOKYO:2264) today announced it has attained self-affirmed GRAS (generally recognized as safe) status in the United States for LAC-Shield, a unique...
View ArticleClik here to view.
Takeda and TiGenix Announce Results of Second Acceptance Period for the...
OSAKA, Japan & LEUVEN, Belgium Takeda Pharmaceutical Company Limited (TSE: 4502): This press release features multimedia. View the full release here:...
View ArticleClik here to view.
森永乳业的专利免疫原性成分LAC-Shield(TM)获得自我检定GRAS认证
东京 (美国商业资讯) — 森永乳业株式会社(Morinaga Milk Industry Co., Ltd., TOKYO:2264)今天宣布，该公司独特的免疫原性成分LAC-Shield已获得美国自我检定GRAS（普遍认可为安全）认证。这一进展允许美国膳食补剂、功能食品和饮料制造商在专为提升免疫功能而设计的产品中添加LAC-ShieldTM。...
View ArticleClik here to view.
PBT434 Data to be Presented at the International Congress of Parkinson’s...
MELBOURNE, Australia & SAN FRANCISCO Prana Biotechnology Ltd (ASX PBT: NASDAQ PRAN) has today announced it will be presenting further pre-clinical evidence for PBT434 at the International...
View ArticleClik here to view.
Seattle Genetics and Astellas Announce Progress in Enfortumab Vedotin...
BOTHELL, Wash. & TOKYO Seattle Genetics, Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced completion of enrollment...
View ArticleClik here to view.
Shionogi Regains Full Rights to Symproic® (naldemedine) in the US
OSAKA, Japan & FLORHAM PARK, N.J. Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President and CEO: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) has announced that effective immediately,...
View ArticleClik here to view.
Takeda Receives Clearance from the United States Federal Trade Commission for...
OSAKA, Japan Takeda Pharmaceutical Company Limited: NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A...
View ArticleClik here to view.
President Clinton to Deliver Closing Keynote Address on Eliminating...
IRVINE, Calif. For the seventh year in a row, U.S. President Bill Clinton will address healthcare leaders and deliver the closing keynote remarks at the 7th Annual World Patient Safety, Science...
View ArticleClik here to view.
武田薬品工業によるシャイアーの買収案を米国連邦取引委員会が承認
大阪 （ビジネスワイヤ） — 武田薬品工業株式会社： 本情報の全部または一部の直接的または間接的な公開、出版、配布が関係する法律の違反となる国・地域においては、そのような公開、出版、配布を禁止します。 武田薬品工業株式会社は、2018年5月8日に発表されたシャイアーplcの買収案（以下、「本買収」）について米国連邦取引委員会（FTC）から無条件の承認を受領したと発表しました。...
View ArticleClik here to view.
Sonic Healthcare Selects Translational Software’s Pharmacogenomics Platform...
BELLEVUE, Wash. Translational Software®, Inc. (TSI), a global leader in the intelligent use of genetic data for clinical decision support, has finalized an agreement with Sonic Genetics, a member of...
View ArticleClik here to view.
武田拟收购Shire plc交易获得美国联邦贸易委员会批准
日本大阪 (美国商业资讯)–武田药品工业株式会社： 如违反相关司法管辖区的法律规定，则不得在该司法管辖区内部分或全部、直接或间接发布、出版或分发本新闻稿。 武田药品工业株式会社（Takeda Pharmaceutical Company Limited ，简称“武田”）宣布已收到美国联邦贸易委员会(FTC)无条件批准2018年5月8日宣布对Shire plc的拟以收购（“收购”）。...
View Article